Presentation: Development of flow cytometric predictive biomarker assay for response to PARP inhibitor (PARPi) therapy in high-grade serous ovarian cancer (HGSOC) (45th Annual Meeting on Women's Cancer)

Working to Eradicate Gynecologic Cancers

257 - Poster Session A
Development of flow cytometric predictive biomarker assay for response to PARP inhibitor (PARPi) therapy in high-grade serous ovarian cancer (HGSOC)

Saturday, March 22, 2014: 1:05 AM

West Exhibit Hall (Tampa Convention Center)

J. M. Lee, N. Gordon, M. J. Lee, J. Trepel, M. Yu and E. C. Kohn
National Cancer Institute, Bethesda, MD